Allen Borchardt, PhD

Director
Cidara Therapeutics

Disclosure: Cidara Therapeutics (Individual(s) Involved: Self): Employee

Presentation(s):

• 159 - efficacy of CD377, a Novel Antiviral Fc-conjugate, Against Seasonal Influenza in Lethal Mouse Infection Models

  Oral Abstract

• 162 - CD377, a Novel Antiviral Fc-conjugate, Demonstrates Potent Viral Burden Reduction Against Influenza a (H1N1) in Mouse and Ferret Models

  Oral Abstract